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[Summary title]
  [Summary text]
Background 
Target condition being diagnosed
Alzheimer's disease (AD) and related forms of dementia are common among older adults with a prevalence of 8% in
individuals over age 65 years increasing to a prevalence of approximately 43% in adults aged 85 years and older (Thies
2012). Given the increasing number of older adults in most developing countries, the prevalence of dementia is
expected to increase considerably in the coming years. Currently, an estimated 5.4 million Americans are diagnosed
with AD and this number is expected to increase to 6.7 million by 2025 (Thies 2012). Alzheimer's disease and related
forms of dementia are currently incurable and result in considerable direct and indirect costs, both in terms of formal
health care and lost productivity from both the affected individual and their caregivers (Thies 2012). There are several
benefits to diagnosing AD and related dementias early in the disease course. Most individuals with dementia, and their
caregivers, would prefer to know a diagnosis of dementia, and earlier diagnosis of AD allows for individuals with AD to
make decisions regarding future planning while they retain the capacity to do so (Prorok 2013). A diagnosis of dementia
is also necessary to access certain services and supports for individuals and their caregivers, and pharmacological
treatments such as cholinesterase inhibitors (Birks 2006; Rolinski 2012) or memantine (McShane 2006; Wilkinson 2012) may
provide temporary symptomatic improvement in cognitive and functional symptoms for individuals with mild to moderate AD.
The diagnosis of AD is clinical and based on a history of decline in cognition with deficits in memory and at least
one other area of cognitive functioning (for example apraxia, agnosia, or executive dysfunction). There must be a
decline from a previous level of functioning which results in significant social or occupational impairment (American
Psychiatric Association 2000; McKhann 2001). A definitive diagnosis of AD can only be achieved at autopsy, but a
clinical diagnosis using standardized criteria is associated with a sensitivity of 81% and a specificity of 70% when
compared to autopsy proven cases (Knopman 2001).
Approximately 50% to 80% of all individuals with dementia are ultimately classified as AD (Blennow 2006; Brunnstrom 2009; 
Canadian Study of Health and Aging 1994). While patients with dementias share common characteristics, subtle
differences can help to provide a diagnosis in the absence of neuropathological examination. Vascular dementias
may occur more abruptly or present with a step-wise decline in cognitive functions over time, and account for
approximately 15% to 20% of dementias (Canadian Study of Health and Aging 1994; Feldman 2003; Lobo 2000).
Dementia with a mixed vascular and Alzheimer's disease pathology is present in 10% to 30% of cases (Brunnstrom 2009; 
Crystal 2000; Feldman 2003). A smaller proportion of dementias are associated with dementia with Lewy bodies
(Brunnstrom 2009) or Parkinson's disease dementia (Aarsland 2005). Patients experiencing frontotemporal
dementia account for a smaller proportion of dementias (4% to 8%) and often present with problems in executive
function and changes in behaviour, while memory is relatively preserved early in the disease course (Brunnstrom 2009; 
Greicius 2002).
Index test(s)
The Mini-Cog is a brief cognitive test consisting of two components, a delayed three word recall and the clock drawing
test (Borson 2000). The Mini-Cog was initially developed in a community setting to provide a relatively brief
cognitive screening test that was free of educational and cultural biases. Different scoring algorithms were tested to
determine which combination had the optimal balance of sensitivity and specificity (McCarten 2011; Scanlan 2001).
The Mini-Cog takes approximately three to five minutes to complete in routine practice (Borson 2000; Holsinger 2007; 
Scanlan 2001). The Mini-Cog has been reported to have little potential for bias with education or language (Borson 2000; 
Borson 2005).
Clinical Pathway 
Dementia typically begins with subtle cognitive changes and progresses gradually over the course of several
years. There is a presumed period when people are asymptomatic although the disease pathology may be
progressing. Individuals or their relatives may first notice subtle impairments of short-term memory or other areas of
cognitive functioning. Gradually, the severity of cognitive deficits become apparent resulting in difficulty completing
complex activities of daily living such as management of finances and medications, or operating motor vehicles (Njegovan
2001). The attribution of cognitive symptoms to normal aging may cause delays in the diagnosis and treatment of AD or
other types of dementia. Therefore, there is a need for accurate brief cognitive screening tests to help distinguish between
the cognitive changes associated with normal aging and changes that might indicate a dementia. In a secondary care setting,
individuals are typically referred from primary care or community health services for further evaluation of possible memory
complaints. Therefore, most individuals in secondary care settings would likely have some cognitive complaints or symptoms
at the time of evaluation. Secondary care settings that would frequently use the Mini-Cog or other screening tests would
include neurology, geriatric medicine, geriatric psychiatry services or memory clinics. Typically, individuals who are assessed
in secondary care settings would receive more detailed neuropsychological testing along with other investigations that are
needed in order to confirm a diagnosis of dementia.
Prior test(s)
As the Mini-Cog is recommended to be used as an initial screening test for dementia it is unlikely that individuals will have
any testing completed prior to the administration of the Mini-Cog.
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Role of index test(s)
Most older adults with memory complaints will first present to their general practitioner or other primary healthcare
provider (for example nurses or a nurse practitioner). Primary healthcare providers may then refer an individual to a
secondary care setting such as a neurologist, geriatrician, or geriatric psychiatrist. Some countries have also
recommended that brief cognitive screening tests be administered to all older adults in order to help screen for
undetected or asymptomatic cognitive impairment (Cordell 2013) although routine screening of older adults for dementia is
controversial. We would anticipate that the Mini-Cog would be utlized as a screening test to guide further evaluation of
cognitive complaints for individuals in secondary care and not as a diagnostic test in most instances.
Alternative test(s)
We are not including alternative tests in this review because there are currently no standard tests available for the diagnosis
of dementia. 
The Cochrane Dementia and Cognitive Improvement Group (CDCIG) is in the process of conducting a series of diagnostic
test accuracy reviews of biomarkers and scales (see the list below). Although the CDCIG is conducting reviews on individual
tests compared to a reference standard, we plan to compare our results in an overview.
Positron emission tomography F-2-fluoro-2-deoxy-D-glucose (18F-FDG-PET)
Positron emission tomography Pittsburg compound-C (11C-PIB-PET)
Structural magnetic resonance imaging (sMRI)
Neuropsychological tests (Mini-Mental State Examination (MMSE); Montreal Cognitive Assessment (MoCA))
Informant interviews (Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE); AD8 Dementia Screening
Interview)
Apolipoprotein E e4 (APOE e4)
Fluoropropil-carbomethoxy-iodophenil-tropane single-photon emission tomography (FP-CIT SPECT)
Rationale
Cognitive diagnostic tests are required to assess cognition and assist in diagnosing conditions such as mild cognitive
impairment and dementia. Comprehensive evaluation, conducted by psychologists or dementia specialists such as
general psychiatrists, geriatric psychiatrists, geriatricians, or neurologists, using standardized diagnostic criteria would
be the reference standard for assessing cognition and diagnosing dementia in older adults. However, access to these
specialized resources is scarce and expensive and as such they are not practical to be used routinely in the
evaluation of cognitive complaints (Pimlott 2009; Yaffe 2008). While there are some cognitive tests that can be performed by
healthcare providers who are not dementia specialists, many of these tests are time consuming and may not be practical to
use as a first-line cognitive screen in secondary care settings. As such, brief but relatively accurate cognitive screening tests
are required for healthcare providers in secondary care settings to identify individuals who may require more in-depth
evaluation of cognition. In secondary care settings, brief cognitive screening tests may be used to guide subsequent
evaluations or to complement more detailed evaluations.
Utilizing a standard cognitive screening test like the Mini-Cog also promotes effective communication between
healthcare providers. Sensitivity and specificity of such tests vary depending upon the setting in which they are
utilized (Holsinger 2007). Some studies have found that in primary care the majority of older adults with dementia
are undiagnosed (Boustani 2005; Sternberg 2000). In addition, many primary care providers have difficulty in accurately
diagnosing dementia, and mild dementia is particularly under-diagnosed (van den 2011). Early diagnosis and
treatment of dementia can have clinical benefits for the patient, their community, and the healthcare system (Bennett 2003; 
Prorok 2013; Thies 2012). Accurate diagnosis of dementia is also important in order to initiate dementia therapeutics
including both non-pharmacological treatments and pharmacological treatments such as cholinesterase inhibitors (Birks
2006; Rolinski 2012) or memantine (McShane 2006). A brief and simple cognitive screening test such as the Mini-
Cog that could be used in secondary care settings would allow healthcare professionals or lay people to initially
screen older adults for the presence of dementia. Individuals that screen positive for cognitive impairment on the
Mini-Cog may then be further investigated for the presence of dementia using additional cognitive tests or other
investigations. Given that the Mini-Cog is brief, widely available, easy to administer, and has been reported to have
reasonable test accuracy properties (Brodaty 2006; Lin 2013) it may be well suited for use as an initial cognitive
screening test in secondary care. The Mini-Cog has been recommended as a suitable cognitive screening test for
primary care in some countries (Cordell 2013). The current review will examine the diagnostic accuracy of the Mini-Cog
in secondary care settings. Separate DTA reviews are being undertaken for community and primary care settings (Fage
2013).
Objectives 
To determine the diagnostic accuracy of the Mini-Cog for detecting Alzheimer's disease dementia and related dementias in a
secondary care setting.
Secondary objectives
To investigate the heterogeneity of test accuracy in the included studies and potential sources of heterogeneity. These
potential sources of heterogeneity will include the baseline prevalence of dementia in study samples, thresholds used to
determine positive test results, the type of dementia (Alzheimer's disease dementia or all causes of dementia), and aspects
of study design related to study quality.
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We will also identify gaps in the evidence where further research is required.
Methods 
Criteria for considering studies for this review
Types of studies 
We included all cross-sectional studies with well-defined populations that utilized the Mini-Cog as an index cognitive
screening test compared to a reference standard. Included studies utilized a reference standard to determine whether or not
a dementia was present. Included studies also utilized the Mini-Cog as a screening test and not for confirmation of diagnosis.
Some studies utilized the test on patients with a previously known diagnosis of AD or a related dementia, but when possible,
studies administered the index and reference tests to individuals where their diagnosis is not already known.
Participants
Study participants were sampled from a secondary care setting and may or may not have ultimately been diagnosed
with AD or a related dementia. Participants may have had cognitive complaints or dementia at baseline although their
cognitive status should not be known to the individual administering the Mini-Cog or the reference standard. Studies on
participants with a developmental disability which prevented them from completing the Mini-Cog were excluded. Studies
including participants in either a community or primary care setting were excluded as these are the topic of other
reviews (Fage 2013).
Index tests
Mini-Cog test
The Mini-Cog consists of a three word recall task and the clock drawing test. The standard scoring system involves
assigning a score of zero to three points on the word recall task for the correct recall of 0, 1, 2, or 3 words,
respectively. The clock drawing test is scored as being either 'normal' or 'abnormal'. A positive test on the Mini-Cog
(that is dementia) is assigned if either the delayed word recall score is zero out of three, or if the delayed recall score
is either one or two and the clock drawing test is abnormal. A score of three on the delayed word recall or one to two
on the delayed word recall with a normal clock drawing is a negative test (that is no dementia) (Borson 2000).
Studies had to include the results of the Mini-Cog. If multiple scoring algorithms were utilized the differences in results was
explored through subgroup analysis.
Target conditions
Target conditions included any stage of AD or other types of dementia including vascular dementia, dementia with Lewy
bodies, Parkinson's disease dementia, or frontotemporal dementia.
Reference standards
While a definitive diagnosis can only be made post-mortem at autopsy, there are clinical criteria for the diagnosis of
most forms of dementia. All dementia diagnostic criteria require that an individual has deficits in multiple areas of
cognition that results in impairment in daily functioning and is not caused by either the effects of a substance or
general medical condition. We have included several potential reference standards for the diagnosis of all-cause
dementia or specific types of dementia. All-cause dementia is commonly diagnosed using criteria such as the
Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) criteria for dementia (American Psychiatric Association
2000), the DSM-5 (American Psychiatric Association 2013) criteria for major neurocognitive disorder, or the
International Classification of Diseases (ICD) diagnosis of dementia (World Health Organization 2010). The
standard clinical diagnostic criteria commonly used for Alzheimer's disease dementia include the National Institute
of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders
Association (NINCDS-ADRDA) criteria for probable or possible dementia (McKhann 1984; McKhann 2011).
Diagnostic criteria for other types of dementia will include the National Institute of Neurological Disorders and Stroke
and Association Internationale pour la Recherché et l'Enseignement en Neurosciences (NINCDS-AIREN) criteria for
vascular dementia (Roman 1993), standard criteria for dementia with Lewy bodies (McKeith 2005) and for
frontotemporal dementia (McKhann 2001). The evaluation often includes laboratory investigations, many of which
are useful for excluding alternative diagnoses (Feldman 2008). Additional procedures to help confirm the diagnosis
include specific findings on neuroimaging (either computed tomography (CT) or magnetic resonance imaging (MRI)).
These investigations are typically used to confirm the diagnosis rather than rule out the possibility of dementia. While
these clinical criteria for dementia are considered the reference standard for the purpose of our review, the sensitivity
and specificity of these clinical reference standards may vary when compared to neuropathological criteria for dementia
(Nagy 1998).
Search methods for identification of studies 
Electronic searches 
We searched MEDLINE (OvidSP), EMBASE (OvidSP), BIOSIS previews (Web of Knowledge), Science Citation Index
(ISI Web of Knowledge), PsycINFO (Ovid SP), LILACS (BIREME), and the Cochrane Dementia Group register of
diagnostic test accuracy studies that is under development. See Appendix 1 for the search strategy used in MEDLINE
(OvidSP) and to view the 'generic' search that is run regularly for the Cochrane Dementia and Cognitive Improvement
Group register of diagnostic test accuracy studies. Similarly, structured search strategies was designed using search
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terms appropriate for each database. Controlled vocabulary such as MeSH terms and EMTREE were used where
appropriate. There was no attempt to restrict studies based on sampling frame or setting in the searches that were
developed. This is to maximize sensitivity and allow inclusion on the basis of population-based sampling to be
assessed at testing (see ‘Selection of studies’). Search filters (collections of terms aimed at reducing the number
need to screen) were not used as an overall limiter because those published have not proved sensitive enough (Whiting
2011). No language restriction was applied to the electronic searches, and we used translation services as necessary.
A single review author with extensive experience in systematic reviews performed the initial searches. Screening of abstracts
and titles were conducted by two independent authors.
Searching other resources 
The reference lists of all relevant studies were searched for additional relevant studies. These studies were also used to
search the electronic databases to identify additional studies through the use of the related article feature. We asked
research groups authoring studies used in the analysis for any unpublished data.
Data collection and analysis 
Selection of studies 
Included studies had to:
1. Make use of the Mini-Cog as a cognitive diagnostic tool.
2. Include patients from a secondary care setting who may or may not have dementia or cognitive complaints. Case-control
studies will not be included in this review.
3. Clearly explain how a diagnosis of dementia was confirmed according to a reference standard such as the DSM IV-TR or
NINCDS-ADRDA at the same time or within the same four week time period that the Mini-Cog was administered. Formal
neuropsychological evaluation was not required for a diagnosis of dementia.
4. Report estimates of test reproducibility, if completed within the study.
Articles were first selected based on the abstracts and titles. Two independent review authors located selected articles and
assessed for inclusion. Disagreements were settled by a third author.
Data extraction and management
Two review authors extracted the following data from all included studies:
Author, journal, and year of publication.
Scoring algorithm for the Mini-Cog including cut-points used to define a positive screen. Method of Mini-Cog
administration including who administered and interpreted the test, their training, and whether or not the readers of the
Mini-Cog and reference standard were blind (masked) to the results of the other test.
Reference criteria and method used to confirm diagnosis of AD or a related dementia.
Baseline demographic characteristics of the study population including age, gender, ethnicity, spectrum of presenting
symptoms, comorbidity, educational achievement, language, baseline prevalence of dementia, country, ApoE status,
methods of participant recruitment and sampling procedures.
Length of time between administration of index test (Mini-Cog) and reference standard.
The sensitivity and specificity, and positive and negative likelihood ratios of the index test in defining dementia.
Version of translation (if applicable).
Prevalence of dementia in the study population.
Assessment of methodological quality
We used the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) criteria to assess data quality (Whiting 2011).
The QUADAS-2 criteria contain assessment domains for patient selection, index test, reference test, and flow and timing.
Each domain has suggested signalling questions to assist with the risk of bias assessment for each domain. The potential
risk of bias associated with each domain is rated as being at high, low, or uncertain risk of bias. In addition, we performed an
assessment of the applicability of the study to the review question for each domain using the guide provided in the
QUADAS-2. We used a standardized risk of bias template to extract data on the risk of bias for each study using the form
provided by the UK Support Unit Cochrane Diagnostic Test Accuracy group. See Appendix 2 for details of the QAUDAS-2.
The quality assessment results were summarized using the methodological quality summary table and methodological
summary graph in RevMan.
Statistical analysis and data synthesis
We performed statistical analysis as per the Cochrane guidelines for diagnostic test accuracy reviews (Macaskill 2010). Two-
by-two tables were constructed separately for the Mini-Cog results for Alzheimer's disease dementia and all-cause dementia
where this information was available.
We entered data from individual studies including the true positives (TP), true negatives (TN), false positives (FP),
and false negatives (FN) into RevMan. We then calculated the sensitivity, specificity, and positive and negative
likelihood ratios as well as measures of statistical uncertainty (for example 95% confidence intervals) in RevMan
from the raw data. Data from each study was presented graphically by plotting sensitivities and specificities on a
coupled forest plot. If there were explicit thresholds across included studies we planned to use the bivariate random-
effects approach for meta-analysis of the sensitivity and specificity (Reitsma 2005). If multiple thresholds were reported
DTA13 Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting
5 / 27
for the Mini-Cog, we planned to use the hierarchical summary receiver operating characteristic (HSROC) method of
Rutter and Gastconis for meta-analysis (Rutter 2001). The diagnostic odds ratio (DOR) was calculated for each study. The
typical algorithm used to score the Mini-Cog is explicit in how the results should be scored. However, where variation from
this scoring scheme was encountered in the literature, the analysis plan changed to incorporate multiple average threshold
points.
Investigations of heterogeneity
The potential sources of heterogeneity included baseline prevalence of cognitive impairment in the target population, the cut-
points used to determine a positive test result, the reference standard used to diagnose dementia, the type of dementia
(Alzheimer's disease dementia or all-cause dementia), the severity of dementia in the study sample, and aspects related to
study quality.
We performed subgroup analyses to investigate the effects of the sources of heterogeneity. These involved visual
examination of the forest plot of sensitivity and specificity and the ROC plot within each subgroup (for example baseline
prevalence, type of dementia, etc). Additionally, we performed a formal analysis using the HSROC model. If necessary, this
model was extended to include covariates to assess whether threshold, accuracy, or the shape of the ROC curve varied with
patient or study characteristics. If the number of studies was limited, we investigated the effect of each source of
heterogeneity by using covariates to estimate differences in both the accuracy and threshold parameters; the underlying
shape of the summary ROC curve was assumed to be constant.
Sensitivity analyses
If not already explored as part of the investigation of heterogeneity, above, we performed a sensitivity analysis in order to
investigate the influence of study quality on overall diagnostic accuracy of the Mini-Cog test. In this analysis we omitted
studies at high risk of bias.
We also determined the impact of individual studies on summary outcome measures.
Assessment of reporting bias
We did not investigate reporting bias because of current uncertainty about how it operates in test accuracy studies and the
interpretation of existing analytical tools such as funnel plots.
Results 
Results of the search
The results of the literature search are summarized in Figure 1. A review of the electronic databases initially in September
2012 identified 108 articles. This search was updated in January 2013 adding an additional 106 and a second update was
completed in February 2015 which identified another 34 potentially relevant citations. The same search strategy was
employed for this review that was used in separate reviews of the Mini-Cog in the community setting () and primary care
setting. After removal of duplications a total of 144 abstracts and citations were reviewed by two authors for inclusion criteria
and suitability for inclusion in the final review.
A total of 40 full-text articles were reviewed for eligibility to be included in the final review. Of these 40 articles, 36 were
excluded due to a lack of a reference standard (N=15), failure to include the Mini-Cog as an index text (N=5), duplicate
publications (N=6), incorrect setting (N=7), or lack of sufficient data to be included in in the review (N=3).
The final search resulted in four studies being included (including five separate research reports). The characteristics of the
studies are outlined in Summary of findings table 1.
Methodological quality of included studies
The results of the QUADAS-2 assessment for the four included studies are presented in Figure 4. Filho 2009 was judged as
being at high risk of bias in the patient selection and flow and timing domains. This was because a consecutive, random
sample of patients was not used, the study did not avoid inappropriate exclusions, and not all patients were included in the
analysis. For Clionsky 2010 and Steenland 2008, it was unclear whether or not a consecutive, random sampling of patients
was employed, but this did not introduce a risk of bias in paient selection. It was also unclear if the Mini-Cog was interpreted
with or without knowledge of the reference standard assessment in Clionsky 2010, but risk of bias was still judged to be low.
Alternatively, it was unclear if the reference standard assessment was interpreted with or without knowledge of the Mini-Cog
results in Filho 2009, but again the risk of bias was judged to be low. There was unclear risk of bias in the conduct or
interpretation of the reference standard assessment for Steenland 2008.
An additional feature common across all four included studies that may have introduced other potential sources of bias was
the index test employed. All studies used a version of the Mini-Cog that was derived from the three-word recall and clock
drawing test components of a larger neuropsychological test (i.e. the MMSE), and furthermore, Filho 2009 utilized a modified
threshold for its index test. The accuracy of the Mini-Cog may have been affected when the result of the Mini-Cog stemmed
from more comprehensive testing compared to when the component tests were administered by themselves.
Findings
There were four study reports, each on unique study populations, that were selected for the final review (Clionsky 2010, 
Filho 2009, Milian 2012, Steenland 2008). The characteristics of these studies are summarized in the Characteristics of
included studies section of this review. Additional features of these studies are also summarized in Summary of findings
table 1. The baseline prevalence of dementia in the overall study samples varied from 32.2% (Filho 2009) to 90.2% (
DTA13 Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting
6 / 27
Clionsky 2010). All studies utilized the original scoring system proposed by Borson et al (Borson 2000), except Filho 2009, in
which a modified threshold was used.
Meta-analysis of the diagnostic test accuracy of the Mini-Cog was planned, although due to the small number of studies,
methodological limitations, and heterogeneity of included studies we did not perform a meta-analysis. The extracted data,
including sensitivity, specificity and forest plots for the Mini-Cog in each study, are summarized in Summary of findings table
1 and in the forest plot presented in Figure 2. The sensitivities of the Mini-Cog in the individual studies were reported
as 0.67 (Clionsky 2010), 0.60 (Filho 2009), 0.87 (Milian 2012), and 0.72 (Steenland 2008). The specificity of the
Mini-Cog for each individual study was 0.88 (Clionsky 2010), 0.65 (Filho 2009), 1.00 (Milian 2012), and 0.13 (Steenland
2008). The values for the positive and negative predictive values and positive and negative liklihood ratios for the individual
studies are summarized in the Summary of findings table 1 and in Figure 2.
The use of meta-analysis to arrive at pooled estimates for the diagnostic test accuracy was not performed due to the
small number of studies, heterogeneity, and overall poor quality of the included studies. The study specific sensitivity
and specificity were plotted in a forest plot (Figure 2) and the summary test characteristics of the individual studies
were plotted in a graph (Figure 3).
Discussion 
Summary of main results
Strengths and weaknesses of the review
Applicability of findings to the review question
Authors' conclusions 
Implications for practice 
Implications for research 
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Differences between protocol and review 
Published notes 
Characteristics of studies
Characteristics of included studies 
Clionsky 2010
Patient Selection
A. Risk of Bias
Patient Sampling
Patients were selected from medical records in
neuropsychology and geriatric psychiatry practices
between 2005 - 2008
Was a consecutive or random sample of patients enrolled? Unclear
Was a case-control design avoided? Yes
Did the study avoid inappropriate exclusions? Yes
Could the selection of patients have introduced bias? Low risk
B. Concerns regarding applicability
Patient characteristics and setting
Patient population was heterogenous in gender
with an average age of 78.2 years old
Are there concerns that the included patients and setting do not match the
review question? Low concern
Index Test
Index tests Mini-Cog scored according to original criteria in Borson 2000
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All tests
A. Risk of Bias
Were the index test results interpreted without knowledge of the results of the reference standard? Unclear
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the index test, its conduct, or interpretation differ from the review question? Lowconcern
Reference Standard
A. Risk of Bias
Target condition and reference standard(s)
Clinical diagnosis of dementia was determined based on
the criteria of DSM-IV by 1 of 6 licensed psychologists.
Psychologists were blind from Mini-Cog results. Patients
were evaluated based on their age and education adjusted
neuropsychological test scores, medical and psychiatric
history and interview with a family informant.
Is the reference standards likely to correctly classify the target
condition? Yes
Were the reference standard results interpreted without
knowledge of the results of the index tests? Yes
Could the reference standard, its conduct, or its interpretation
have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the target condition as defined by the reference standard does not match the question? Lowconcern
Flow and Timing
A. Risk of Bias
Flow and timing
All patients received both index tests and
reference standard.
Was there an appropriate interval between index test and reference standard? Yes
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Notes
Notes  
Filho 2009
Patient Selection
A. Risk of Bias
Patient Sampling
Convenient sample of 306 individuals, 65 years
old or older, seeking medical treatment as
outpatients at Internal Medicine Clinic of the
Policlinica Piquet Carneiro at Rio de Janeiro State
University Hospital. Sampling limited by the
number of consenting individuals and number of
screening spots open for each day. Occassionally,
patients return next day to finishing their testing.
Was a consecutive or random sample of patients enrolled? No
Was a case-control design avoided? Yes
Did the study avoid inappropriate exclusions? No
Could the selection of patients have introduced bias? High risk
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B. Concerns regarding applicability
Patient characteristics and setting
Patients seeking general medical treatment were
invited to participate. Those over 65 years old
without serious visual and auditory deficient,
mental illness affecting their understanding of
testing procedures were not eligible for the
screening tests. Non-native Portuguese speakers
and elders with hand movement difficulties were
excluded.
Are there concerns that the included patients and setting do not match
the review question? Unclear
Index Test
Index tests
Mini-Cog testing as described by Borson (2000) with a modified threshold for diagnosing dementia. A
threshold of 2/3 was chosen instead of the 3/5 threshold as described by Borson (2000)
All tests
A. Risk of Bias
Were the index test results interpreted without knowledge of the results of the reference standard? Yes
If a threshold was used, was it pre-specified? No
Could the conduct or interpretation of the index test have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the index test, its conduct, or interpretation differ from the review question? Unclear
Reference Standard
A. Risk of Bias
Target condition and reference standard(s)
Diagnosis of dementia based on the formal criteria of
DSM-IV evaluated based on clinical impression and
neuropsychological evaluation, which includes some
components of the index tests, as agreed upon between
geriatrician and neuropsychologist.
Is the reference standards likely to correctly classify the target
condition? Yes
Were the reference standard results interpreted without
knowledge of the results of the index tests? Unclear
Could the reference standard, its conduct, or its interpretation
have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the target condition as defined by the reference standard does not match the question? Lowconcern
Flow and Timing
A. Risk of Bias
Flow and timing
No intervention/ treatment occurred between
index test and the reference standard.
Ocassionally, the index test and reference tests
were administered on different days. Patients
who were lost in follow up and those who did
not finish their evaluation were excluded.
Was there an appropriate interval between index test and reference
standard? Yes
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? No
Could the patient flow have introduced bias? High risk
Notes
Notes  
Milian 2012
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A. Risk of Bias
Patient Sampling
Patient selected retrospectively from all admitted
patients to the Memory Clinic of the Departent of
Psychiatry and Psychotherapy of the University
Hospital of Tubingen between 2004 to 2009.
Was a consecutive or random sample of patients enrolled? Yes
Was a case-control design avoided? Yes
Did the study avoid inappropriate exclusions? Yes
Could the selection of patients have introduced bias? Low risk
B. Concerns regarding applicability
Patient characteristics and setting
Patient sample composed of older adults
from both gender, with normal visual acuity
and sufficient hearing, wide education range.
Patients with severe handicap affecting
required tasks, mild cognitive impairment
and depressive episodes were excluded
from this analysis. Also, patients with
underlying neurological and psychiatric
disorder unrelated to the diagnosis of
dementia were excluded.
Are there concerns that the included patients and setting do not match the
review question? Low concern
Index Test
Index tests Mini-Cog administered with original scoring, as per Borson 2000.
All tests
A. Risk of Bias
Were the index test results interpreted without knowledge of the results of the reference standard? Yes
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the index test, its conduct, or interpretation differ from the review question? Lowconcern
Reference Standard
A. Risk of Bias
Target condition and reference standard(s)
Diagnosis of dementia based on the
formal criteria of DSM-IV, ICD-10 of
Mental & Behavior Disorder by the WHO
and NINCDS-ADRDA
Is the reference standards likely to correctly classify the target condition? Yes
Were the reference standard results interpreted without knowledge of the results
of the index tests? Yes
Could the reference standard, its conduct, or its interpretation have introduced
bias? Low risk
B. Concerns regarding applicability
Are there concerns that the target condition as defined by the reference standard does not match the question? Lowconcern
Flow and Timing
A. Risk of Bias
Flow and timing
The index test and reference standard
were determined in succession by blinded
assessors.
Was there an appropriate interval between index test and reference standard? Yes
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
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Milian 2013
Patient Selection
A. Risk of Bias
Patient Sampling Memory clinic
Was a consecutive or random sample of patients enrolled? Unclear
Was a case-control design avoided? Yes
Did the study avoid inappropriate exclusions? Yes
Could the selection of patients have introduced bias? Low risk
B. Concerns regarding applicability
Patient characteristics and setting Not specified
Are there concerns that the included patients and setting do not match the review
question? Low concern
Index Test
Index tests
The Mini-cog was completed by the individuals completing the reference standard. The scoring was
standard scoring and the 3 word recall was derived from the MMSE.
All tests
A. Risk of Bias
Were the index test results interpreted without knowledge of the results of the reference standard? Yes
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the index test, its conduct, or interpretation differ from the review question? Lowconcern
Reference Standard
A. Risk of Bias
Target condition and reference standard(s)
Diagnosis of dementia according to ICD-10,
NINCDS-ADRDA conducted by two
psychiatrists
Is the reference standards likely to correctly classify the target condition? Yes
Were the reference standard results interpreted without knowledge of the
results of the index tests? No
Could the reference standard, its conduct, or its interpretation have
introduced bias? High risk
B. Concerns regarding applicability
Are there concerns that the target condition as defined by the reference standard does not match the question? Lowconcern
Flow and Timing
A. Risk of Bias
Flow and timing
The interval between index and reference
were not specified and no description of
patient drop outs were provided.
Was there an appropriate interval between index test and reference standard? Unclear
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Unclear
Could the patient flow have introduced bias? Low risk
Notes
Notes  
Steenland 2008
Patient Selection
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A. Risk of Bias
Patient Sampling
Patients without prior history of dementia
were sampled from the outpatient Geriatric
Medicine Clinic at Wesley Woods Center of
Emory University of Medicine. Patients
were also sampled from registry of
research volunteers at the Emory
Alzheimer's Disease Research Center.
Was a consecutive or random sample of patients enrolled? Unclear
Was a case-control design avoided? Yes
Did the study avoid inappropriate exclusions? Yes
Could the selection of patients have introduced bias? Low risk
B. Concerns regarding applicability
Patient characteristics and setting
Patients suspected of possible cognitive
deficits, or family expressed concern about
cognitive decline were referred by
geriatricians.
Are there concerns that the included patients and setting do not match the
review question? Low concern
Index Test
Index tests Mini-Cog scored according to original scoring algorithm as per Borson 2000.
All tests
A. Risk of Bias
Were the index test results interpreted without knowledge of the results of the reference standard? Yes
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have introduced bias? Low risk
B. Concerns regarding applicability
Are there concerns that the index test, its conduct, or interpretation differ from the review question? Lowconcern
Reference Standard
A. Risk of Bias
Target condition and reference standard(s)
Clinical diagnosis of dementia based on evaluations by two
experienced behavioral neurologists individually reviewing
clinical history of all participants and neuropsychologists'
impression.
Is the reference standards likely to correctly classify the target
condition? Unclear
Were the reference standard results interpreted without
knowledge of the results of the index tests? Yes
Could the reference standard, its conduct, or its interpretation
have introduced bias? Unclear risk
B. Concerns regarding applicability
Are there concerns that the target condition as defined by the reference standard does not match the question? Unclear
Flow and Timing
A. Risk of Bias
Flow and timing
All patients completed both the index test
and reference standard at the same time.
Was there an appropriate interval between index test and reference standard? Yes
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? No
Could the patient flow have introduced bias? Low risk
Notes
Notes  
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Characteristics of excluded studies 
Chen 2011
Reason for exclusion Participants were not without dementia or cognitive complaints at baseline. Study did
not receive gold standard evaluation using standardized diagnostic criteria.
 
Dash 2004
Reason for exclusion Participants were not without dementia or aconative complaints at baseline. Study did
not receive gold standard evaluation using standardized diagnostic criteria.
 
Del Ser 2000
Reason for exclusion Study did not use Mini-Cog as index test. Participants were not without dementia or
cognitive complaints at baseline.
 
Dougherty Jr 2010
Reason for exclusion Participants were not without dementia or cognitive complaints at baseline.
 
Sonnett 2012
Reason for exclusion Study did not receive gold standard evaluation using standardized diagnostic criteria.
 
Wilber 2005
Reason for exclusion Study did not receive gold standard evaluation using standardized diagnostic criteria.
 
Wright 2011
Reason for exclusion Study did not use Mini-Cog as Index test.
 
Footnotes
Characteristics of studies awaiting classification 
Footnotes
Characteristics of ongoing studies 
Footnotes
Summary of results tables
1 New Summary of findings table
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Title: Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting
Population Patients from secondary care setting
Setting Studies with patients recruited from secondary care settings and evaluated using the Mini-Cog andreference standard were included.
Index Test Mini-Cog was derived from CDT and 3 word recall from the MMSE. Standard scoring was used.
Reference
Standard Clinical diagnosis of dementia using recognized standardized dementia criteria.
Studies Cross-sectional studies were included.      
Study
Accuracy
(95% CI)
Number of
participants
Dementia
prevalence
Implications
Clionsky 2010
Sensitivity: 0.67 (0.63 to 0.71)
Specificity: 0.88 (0.76 to 0.95)
Positive LR: 5.58
Negative LR: 0.375
572 90.2%  
Filho 2009
Sensitivity: 0.60 (0.48 to 0.72)
Specificity: 0.65 (0.57 to 0.73)
Positive LR: 1.71
Negative LR: 0.615
211 32.2%  
Milian 2012
Sensitivity: 0.87 (0.83 to 0.90)
Specificity: 1.00 (0.94 to 1.00)
Positive LR: 0.00
Negative LR: 0.13
502 87.3%  
Steenland 2008
Sensitivity: 0.72 (0.58 to 0.83)
Specificity: 0.13 (0.06 to 0.24)
Positive LR: 0.83
Negative LR: 2.15
125 45.6%  
Footnotes
Additional tables 
1 Characteristics of included studies
Study IDCountryParticipants(N) Setting Mini-Cog scoringDementiadiagnosisDementiaprevalence Notes
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Caption
Study flow diagram.
Figure 2 (Analysis 1) 
Caption
Forest plot of 1 Mini-Cog in Tertiary Setting.
Figure 3 (Analysis 1) 
Caption
Summary ROC Plot of 1 Mini-Cog in Tertiary Setting.
Figure 4
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Caption
Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages
across included studies
Figure 5
Caption
Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study
Sources of support 
Internal sources
No sources of support provided
External sources
No sources of support provided
Feedback 
Appendices 
1 MEDLINE search strategy
The Mini-Cog search will utilize only one search concept: the index test (Mini-Cog):
1. "mini-Cog".ti,ab.
2. minicog.ti,ab.
3. (MCE and (cognit* OR dement* OR screen* OR Alzheimer*)).ti,ab.
4. or/1-3
The MEDLINE generic search run for the CDCIG DTA register:
1. "word recall".ti,ab.
2. ("7-minute screen" OR “seven-minute screen”).ti,ab.
3. ("6 item cognitive impairment test" OR “six-item cognitive impairment test”).ti,ab.
4. "6 CIT".ti,ab.
5. "AB cognitive screen".ti,ab.
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6. "abbreviated mental test".ti,ab.
7. "ADAS-cog".ti,ab.
8. AD8.ti,ab.
9. "inform* interview".ti,ab.
10. "animal fluency test".ti,ab.
11. "brief alzheimer* screen".ti,ab.
12. "brief cognitive scale".ti,ab.
13. "clinical dementia rating scale".ti,ab.
14. "clinical dementia test".ti,ab.
15. "community screening interview for dementia".ti,ab.
16. "cognitive abilities screening instrument".ti,ab.
17. "cognitive assessment screening test".ti,ab.
18. "cognitive capacity screening examination".ti,ab.
19. "clock drawing test".ti,ab.
20. "deterioration cognitive observee".ti,ab.
21. ("Dem Tect" OR DemTect).ti,ab.
22. "object memory evaluation".ti,ab.
23. "IQCODE".ti,ab.
24. "mattis dementia rating scale".ti,ab.
25. "memory impairment screen".ti,ab.
26. "minnesota cognitive acuity screen".ti,ab.
27. "mini-cog".ti,ab.
28. "mini-mental state exam*".ti,ab.
29. "mmse".ti,ab.
30. "modified mini-mental state exam".ti,ab.
31. "3MS".ti,ab.
32. “neurobehavio?ral cognitive status exam*”.ti,ab.
33. "cognistat".ti,ab.
34. "quick cognitive screening test".ti,ab.
35. "QCST".ti,ab.
36. "rapid dementia screening test".ti,ab.
37. "RDST".ti,ab.
38. "repeatable battery for the assessment of neuropsychological status".ti,ab.
39. "RBANS".ti,ab.
40. "rowland universal dementia assessment scale".ti,ab.
41. "rudas".ti,ab.
42. "self-administered gerocognitive exam*".ti,ab.
43. ("self-administered" and "SAGE").ti,ab.
44. "self-administered computerized screening test for dementia".ti,ab.
45. "short and sweet screening instrument".ti,ab.
46. "sassi".ti,ab.
47. "short cognitive performance test".ti,ab.
48. "syndrome kurztest".ti,ab.
49. ("six item screener" OR “6-item screener”).ti,ab.
50. "short memory questionnaire".ti,ab.
51. ("short memory questionnaire" and "SMQ").ti,ab.
52. "short orientation memory concentration test".ti,ab.
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53. "s-omc".ti,ab.
54. "short blessed test".ti,ab.
55. "short portable mental status questionnaire".ti,ab.
56. "spmsq".ti,ab.
57. "short test of mental status".ti,ab.
58. "telephone interview of cognitive status modified".ti,ab.
59. "tics-m".ti,ab.
60. "trail making test".ti,ab.
61. "verbal fluency categories".ti,ab.
62. "WORLD test".ti,ab.
63. "general practitioner assessment of cognition".ti,ab.
64. "GPCOG".ti,ab.
65. "Hopkins verbal learning test".ti,ab.
66. "HVLT".ti,ab.
67. "time and change test".ti,ab.
68. "modified world test".ti,ab.
69. "symptoms of dementia screener".ti,ab.
70. "dementia questionnaire".ti,ab.
71. "7MS".ti,ab.
72. ("concord informant dementia scale" or CIDS).ti,ab.
73. (SAPH or "dementia screening and perceived harm*").ti,ab.
74. or/1-73
75. exp Dementia/
76. Delirium, Dementia, Amnestic, Cognitive Disorders/
77. dement*.ti,ab.
78. alzheimer*.ti,ab.
79. AD.ti,ab.
80. ("lewy bod*" or DLB or LBD or FTD or FTLD or “frontotemporal lobar degeneration” or “frontaltemporal dement*).ti,ab.
81. "cognit* impair*".ti,ab.
82. (cognit* adj4 (disorder* or declin* or fail* or function* or degenerat* or deteriorat*)).ti,ab.
83. (memory adj3 (complain* or declin* or function* or disorder*)).ti,ab.
84. or/75-83
85. exp "sensitivity and specificity"/
86. "reproducibility of results"/
87. (predict* adj3 (dement* or AD or alzheimer*)).ti,ab.
88. (identif* adj3 (dement* or AD or alzheimer*)).ti,ab.
89. (discriminat* adj3 (dement* or AD or alzheimer*)).ti,ab.
90. (distinguish* adj3 (dement* or AD or alzheimer*)).ti,ab.
91. (differenti* adj3 (dement* or AD or alzheimer*)).ti,ab.
92. diagnos*.ti.
93. di.fs.
94. sensitivit*.ab.
95. specificit*.ab.
96. (ROC or "receiver operat*").ab.
97. Area under curve/
98. ("Area under curve" or AUC).ab.
99. (detect* adj3 (dement* or AD or alzheimer*)).ti,ab.
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100. sROC.ab.
101. accura*.ti,ab.
102. (likelihood adj3 (ratio* or function*)).ab.
103. (conver* adj3 (dement* or AD or alzheimer*)).ti,ab.
104. ((true or false) adj3 (positive* or negative*)).ab.
105. ((positive* or negative* or false or true) adj3 rate*).ti,ab.
106. or/85-105
107. exp dementia/di
108. Cognition Disorders/di [Diagnosis]
109. Memory Disorders/di
110. or/107-109
111. *Neuropsychological Tests/
112. *Questionnaires/
113. Geriatric Assessment/mt
114. *Geriatric Assessment/
115. Neuropsychological Tests/mt, st
116. "neuropsychological test*".ti,ab.
117. (neuropsychological adj (assess* or evaluat* or test*)).ti,ab.
118. (neuropsychological adj (assess* or evaluat* or test* or exam* or battery)).ti,ab.
119. Self report/
120. self-assessment/ or diagnostic self evaluation/
121. Mass Screening/
122. early diagnosis/
123. or/111-122
124. 74 or 123
125. 110 and 124
126. 74 or 123
127. 84 and 106 and 126
128. 74 and 106
129. 125 or 127 or 128
130. exp Animals/ not Humans.sh.
131. 129 not 130
2 QUADAS-2
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Domain Patient selection Index test Reference standard Flow and timing
Description
 
Describe methods of
patient selection:
describe included
patients (prior testing,
presentation, intended
use of index test and
setting)
Describe the index
test and how it was
conducted and
interpreted
Describe the reference
standard and how it
was conducted and
interpreted
Describe any patients who did not
receive the index test(s) and/or
reference standard or who were
excluded from the 2 x 2 table (refer
to flow diagram): describe the time
interval and any interventions
between index test(s) and reference
standard
Signalling
questions
(yes, no,
unclear)
 
Was a consecutive or
random sample of
patients enrolled?
Was a case-control
design avoided?
Did the study avoid
inappropriate
exclusions?
 
Were the index test
results interpreted
without knowledge of
the results of the
reference standard?
If a threshold was
used, was it pre-
specified?
 
Is the reference
standard likely to
correctly classify the
target condition?
Were the reference
standard results
interpreted without
knowledge of the
results of the index
test?
 
Was there an appropriate interval
between index test(s) and reference
standard?
Did all patients receive the same
reference standard?
Were all patients included in the
analysis?
Risk of bias:
(high, low,
unclear)
Could the selection of
patients have introduced
bias?
Could the conduct or
interpretation of the
index test have
introduced bias?
Could the reference
standard, its conduct,
or its interpretation
have introduced bias?
Could the patient flow have
introduced bias?
Concerns
regarding
applicability:
(high, low,
unclear)
Are there concerns that
the included patients do
not match the review
question?
Are there concerns
that the index test, its
conduct, or
interpretation differ
from the review
question?
Are there concerns that
the target condition as
defined by the
reference standard
does not match the
review question?
—
Anchoring statements to assist with assessment of risk of bias
Domain 1: patient selection
Risk of bias: could the selection of patients have introduced bias? (high, low, unclear)
Was a consecutive or random sample of patients enrolled?
Where sampling is used, the methods least likely to cause bias are consecutive sampling or random sampling, which should
be stated and/or described. Non-random sampling or sampling based on volunteers is more likely to be at high risk of bias.
Weighting: high risk of bias
Was a case-control design avoided?
Case-control study designs have a high risk of bias, but sometimes they are the only studies available especially if the index
test is expensive and/or invasive. Nested case-control designs (systematically selected from a defined population cohort) are
less prone to bias but they will still narrow the spectrum of patients that receive the index test. Study designs (both cohort
and case-control) that may also increase bias are those designs where the study team deliberately increase or decrease the
proportion of subjects with the target condition, for example a population study may be enriched with extra dementia subjects
from a secondary care setting.
Weighting: high risk of bias
Did the study avoid inappropriate exclusions?
We will automatically grade the study as unclear if exclusions are not detailed (pending contact with study authors). Where
exclusions are detailed, we will grade the study as 'low risk' if exclusions are felt to be appropriate by the review authors.
Certain exclusions common to many studies of dementia are: medical instability; terminal disease; alcohol/substance misuse;
concomitant psychiatric diagnosis; other neurodegenerative condition. However if 'difficult to diagnose' groups are excluded
this may introduce bias, so exclusion criteria must be justified. For a community sample we would expect relatively few
exclusions. We will label post hoc exclusions 'high risk' of bias.
Weighting: high risk of bias
Applicability: are there concerns that the included patients do not match the review question? (high, low, unclear)
The included patients should match the intended population as described in the review question. If not already specified in
the review inclusion criteria, setting will be particularly important – the review authors should consider population in terms of
symptoms; pre-testing; potential disease prevalence. We will classify studies that use very selected subjects or subgroups as
having low applicability, unless they are intended to represent a defined target population, for example, people with memory
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problems referred to a specialist and investigated by lumbar puncture.
Domain 2: index test
Risk of bias: could the conduct or interpretation of the index test have introduced bias? (high, low, unclear)
Were the index test results interpreted without knowledge of the reference standard?
Terms such as 'blinded' or 'independently and without knowledge of' are sufficient and full details of the blinding procedure
are not required. This item may be scored as 'low risk' if explicitly described or if there is a clear temporal pattern to the order
of testing that precludes the need for formal blinding, i.e. all (neuropsychological test) assessments were performed before
the dementia assessment. As most neuropsychological tests are administered by a third party, knowledge of dementia
diagnosis may influence their ratings; tests that are self administered, for example using a computerized version, may have
less risk of bias.
Weighting: high risk of bias
Were the index test thresholds pre-specified?
For neuropsychological scales there is usually a threshold above which subjects are classified as 'test positive'; this may be
referred to as threshold, clinical cut-off or dichotomisation point. Different thresholds are used in different populations. A
study is classified as at higher risk of bias if the authors define the optimal cut-off post hoc based on their own study data.
Certain papers may use an alternative methodology for analysis that does not use thresholds and these papers should be
classified as not applicable.
Weighting: low risk of bias
Were sufficient data on (neuropsychological test) application given for the test to be repeated in an independent study?
Particular points of interest include method of administration (for example self completed questionnaire versus direct
questioning interview); nature of informant; language of assessment. If a novel form of the index test is used, for example a
translated questionnaire, details of the scale should be included and a reference given to an appropriate descriptive text, and
there should be evidence of validation.
Weighting: low risk of bias
Applicability: are there concerns that the index test, its conduct, or interpretation differ from the review question? (high, low,
unclear)
Variations in the length, structure, language, and/or administration of the index test may all affect applicability if they vary
from those specified in the review question.
Domain 3: reference standard
Risk of bias: could the reference standard, its conduct, or its interpretation have introduced bias? (high, low, unclear)
Is the reference standard likely to correctly classify the target condition?
Commonly used international criteria to assist with clinical diagnosis of dementia include those detailed in DSM-IV and
ICD-10. Criteria specific to dementia subtypes include but are not limited to NINCDS-ADRDA criteria for Alzheimer's
dementia; McKeith criteria for Lewy Body dementia; Lund criteria for frontotemporal dementias; and the NINDS-AIREN
criteria for vascular dementia. Where the criteria used for assessment are not familiar to the review authors and the
Cochrane Dementia and Cognitive Improvement Group this item should be classified as 'high risk of bias'.
Weighting: high risk of bias
Were the reference standard results interpreted without knowledge of the results of the index test?
Terms such as 'blinded' or 'independent' are sufficient and full details of the blinding procedure are not required. This may be
scored as 'low risk' if explicitly described or if there is a clear temporal pattern to order of testing, that is, all dementia
assessments performed before (neuropsychological test) testing.
Informant rating scales and direct cognitive tests present certain problems. It is accepted that informant interview and
cognitive testing is a usual component of clinical assessment for dementia, however specific use of the scale under review in
the clinical dementia assessment should be scored as high risk of bias.
Weighting: high risk of bias
Was sufficient information on the method of dementia assessment given for the assessment to be repeated in an
independent study?
Particular points of interest for dementia assessment include the training and expertise of the assessor, whether additional
information was available to inform the diagnosis (for example, neuroimaging, other neuropsychological test results), and
whether this was available for all participants.
Weighting: variable risk, but high risk if method of dementia assessment not described
Applicability: are there concerns that the target condition as defined by the reference standard does not match the review
question? (high, low, unclear)
There is the possibility that some methods of dementia assessment, although valid, may diagnose a far smaller or larger
proportion of subjects with disease than in usual clinical practice. For example, currently the reference standard for vascular
dementia may under-diagnose compared to usual clinical practice. In this instance the item should be rated as having poor
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applicability.
Domain 4: patient flow and timing
Risk of bias: could the patient flow have introduced bias? (high, low, unclear)
Was there an appropriate interval between the index test and reference standard?
For a cross-sectional study design, there is potential for the subject to change between assessments, however dementia is a
slowly progressive disease, which is not reversible. The ideal scenario would be a same-day assessment, but longer periods
of time (for example several weeks or months) are unlikely to lead to a high risk of bias. For delayed-verification studies the
index and reference tests are necessarily separated in time given the nature of the condition.
Weighting: low risk of bias
Did all subjects receive the same reference standard?
There may be scenarios where subjects who score 'test positive' on the index test have a more detailed assessment for the
target condition. Where dementia assessment (or reference standard) differs between subjects this should be classified as
high risk of bias.
Weighting: high risk of bias
Were all subjects included in the final analysis?
Attrition will vary with study design. Delayed verification studies will have higher attrition than cross-sectional studies due to
mortality, and it is likely to be greater in subjects with the target condition. Dropouts (and missing data) should be accounted
for. Attrition that is higher than expected (compared to other similar studies) should be treated as a high risk of bias. We have
defined a cut-off of greater than 20% attrition as being high risk but this will be highly dependent on the length of follow-up in
individual studies.
Weighting: high risk of bias
Graphs
DTA13 Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting
27 / 27
